COVID-19Autoimmune hemolytic anemiaImmune thrombocytopeniaEvans syndromeSARS-coronavirus-2Evans' syndrome (ES) is a rare and chronic autoimmune disease characterized by the concomitant or sequential association of auto-immune hemolytic anemia (AIHA) with immune thrombocytopenia (ITP), and less frequently ...
Using single-cell RNA sequencing, the researchers identified the different cell types present in the lungs before COVID-19 infection (left), in the first few days of infection (center), and towards the end of infection (right). Each color represents a different cell type. The red represents ...
outbreaks—both behaviors that can mitigate as well as those that can facilitate the spread of infection—it is critical that public health decision-makers, health officials, and health care providers understand the nature and degree of adverse psychological responses to the current COVID-19 crisis....
Most unexpected deaths occurred in the setting of COVID-19 infection with the progression of more severe illness symptoms. With the exception of 3 cases, each of the patients who died had been transferred back to the hospital and received medical or intensive care unit–level care for several ...
The diffusion and utilisation of significant knowledge during the pandemic is crucial. Openness to knowledge in and out of crises Fourth, not only “lessons learned” but also “lessons neglected” could be crucial. As COVID-19 impacts firms; “lessons learned” could help generate “implications...
(16.22%, 6/37), circulatory diseases (8.10%, 3/37), digestive diseases (2.70%, 1/37), urinary diseases (2.70%, 1/37), endocrine diseases (2.70%, 1/37), nervous system (5.41%, 2/37), car accident (2.70%, 1/37) and immuno- suppression after COVID-19 infection (2.70%, 1/37...
Recovery from SARS CoV-2 infection is expected within 3 months. Long COVID occurs after SARS-CoV-2 when symptoms are present for more than 3 months that are continuous, relapsing and remitting, or progressive. Better understanding of Long COVID
Cardiac symptoms are increasingly recognized as late complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in previously well individuals with mild initial illness, but the underlying pathophysiology leading to long-term
(Regeneron's investigational multi-antibody therapy for the treatment and prevention of COVID-19); how long the Emergency Use Authorization ("EUA") granted by the U.S. Food and Drug Administration (the "FDA") for casirivimab and imdevimab will remain in effect ...
The COVID-19 pandemic surprised the world with its rapid spread and has had a major impact on the lives of billions of people. Imaging is playing a role in the fight against the disease, in some countries as a key tool, from screening and diagnosis through the entire treatment process, ...